share_log

BioAffinity Technologies Receives Additional $7.7M From Exercise Of Warrants

BioAffinity Technologies Receives Additional $7.7M From Exercise Of Warrants

生物親和技術公司通過行使認股權證獲得額外770萬美元
Benzinga Real-time News ·  2022/09/28 08:16

bioAffinity Technologies, Inc. (NASDAQ:BIAF) (NASDAQ:BIAFW) today announced the receipt of approximately $7.7 million in additional gross proceeds from the exercise of tradeable and non-tradable warrants issued in the Company's September 6, 2022, public offering of securities.

亞洲網加利福尼亞州聖克拉拉9月6日電生物親和技術公司(納斯達克代碼:BIAF)(納斯達克代碼:BIAFW)今天宣佈,通過行使該公司2022年9月6日公開發行的證券認股權證,獲得了大約770萬美元的額外毛收入。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論